Connection

David Jollow to Rats

Back to Details
This is a "connection" page, showing publications David Jollow has written about Rats.
David Jollow
Connection Strength
0.624
Rats
  1. Lipids versus proteins as major targets of pro-oxidant, direct-acting hemolytic agents. Toxicol Sci. 2005 Nov; 88(1):274-83.
    View in: PubMed
    Score: 0.035
  2. Role of oxidant stress in lawsone-induced hemolytic anemia. Toxicol Sci. 2004 Dec; 82(2):647-55.
    View in: PubMed
    Score: 0.033
  3. Favism: effect of divicine on rat erythrocyte sulfhydryl status, hexose monophosphate shunt activity, morphology, and membrane skeletal proteins. Toxicol Sci. 2001 Aug; 62(2):353-9.
    View in: PubMed
    Score: 0.027
  4. Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline. J Pharmacol Exp Ther. 2001 May; 297(2):509-15.
    View in: PubMed
    Score: 0.026
  5. Favism: divicine hemotoxicity in the rat. Toxicol Sci. 1999 Oct; 51(2):310-6.
    View in: PubMed
    Score: 0.024
  6. Role of lipid peroxidation in dapsone-induced hemolytic anemia. J Pharmacol Exp Ther. 1998 Dec; 287(3):868-76.
    View in: PubMed
    Score: 0.022
  7. Formation of free radicals and protein mixed disulfides in rat red cells exposed to dapsone hydroxylamine. Free Radic Biol Med. 1997; 22(7):1183-93.
    View in: PubMed
    Score: 0.019
  8. Dapsone-induced hemolytic anemia: effect of dapsone hydroxylamine on sulfhydryl status, membrane skeletal proteins and morphology of human and rat erythrocytes. J Pharmacol Exp Ther. 1995 Jul; 274(1):540-7.
    View in: PubMed
    Score: 0.018
  9. Macrophage enhancement of galactosamine hepatotoxicity using a rat hepatocyte culture system. Res Commun Mol Pathol Pharmacol. 1995 Jun; 88(3):327-38.
    View in: PubMed
    Score: 0.017
  10. Dapsone-induced hemolytic anemia: role of glucose-6-phosphate dehydrogenase in the hemolytic response of rat erythrocytes to N-hydroxydapsone. J Pharmacol Exp Ther. 1995 May; 273(2):870-7.
    View in: PubMed
    Score: 0.017
  11. Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology. 1995 Apr; 21(4):1045-50.
    View in: PubMed
    Score: 0.017
  12. Identification of free radicals produced in rat erythrocytes exposed to hemolytic concentrations of phenylhydroxylamine. Free Radic Biol Med. 1995 Feb; 18(2):279-85.
    View in: PubMed
    Score: 0.017
  13. Chemical analysis and hemolytic activity of the fava bean aglycon divicine. Chem Res Toxicol. 1993 Jul-Aug; 6(4):439-44.
    View in: PubMed
    Score: 0.015
  14. Dapsone-induced hemolytic anemia: effect of N-hydroxy dapsone on the sulfhydryl status and membrane proteins of rat erythrocytes. Toxicol Appl Pharmacol. 1992 Dec; 117(2):208-17.
    View in: PubMed
    Score: 0.015
  15. Galactosamine hepatotoxicity: effect of galactosamine on glutathione resynthesis in rat primary hepatocyte cultures. Toxicol Appl Pharmacol. 1992 Aug; 115(2):234-40.
    View in: PubMed
    Score: 0.014
  16. The role of N-hydroxyphenetidine in phenacetin-induced hemolytic anemia. Toxicol Appl Pharmacol. 1991 Oct; 111(1):1-12.
    View in: PubMed
    Score: 0.014
  17. Role of metabolites in propanil-induced hemolytic anemia. Toxicol Appl Pharmacol. 1991 Aug; 110(1):70-8.
    View in: PubMed
    Score: 0.013
  18. Arylamine-induced hemolytic anemia: electron spin resonance spectrometry studies. Adv Exp Med Biol. 1991; 283:253-5.
    View in: PubMed
    Score: 0.013
  19. Contribution of 3,4-dichlorophenylhydroxylamine in propanil-induced hemolytic anemia. Adv Exp Med Biol. 1991; 283:343-5.
    View in: PubMed
    Score: 0.013
  20. Effects of sulfur-amino acid-deficient diets on acetaminophen metabolism and hepatotoxicity in rats. Toxicol Appl Pharmacol. 1989 Nov; 101(2):356-69.
    View in: PubMed
    Score: 0.012
  21. Effect of cobalt protoporphyrin on hepatic drug-metabolizing enzymes. Specificity for cytochrome P-450. Biochem Pharmacol. 1989 Jun 15; 38(12):2027-38.
    View in: PubMed
    Score: 0.012
  22. Effect of glucose and gluconeogenic substrates on fasting-induced suppression of acetaminophen glucuronidation in the rat. Biochem Pharmacol. 1989 Jan 15; 38(2):289-97.
    View in: PubMed
    Score: 0.011
  23. Mechanism of decreased acetaminophen glucuronidation in the fasted rat. Biochem Pharmacol. 1988 Mar 15; 37(6):1067-75.
    View in: PubMed
    Score: 0.011
  24. Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia. J Pharmacol Exp Ther. 1988 Jan; 244(1):118-25.
    View in: PubMed
    Score: 0.010
  25. Contribution of aniline metabolites to aniline-induced methemoglobinemia. Mol Pharmacol. 1987 Sep; 32(3):423-31.
    View in: PubMed
    Score: 0.010
  26. Mechanisms of fasting-induced potentiation of acetaminophen hepatotoxicity in the rat. Biochem Pharmacol. 1987 Feb 15; 36(4):427-33.
    View in: PubMed
    Score: 0.010
  27. Use of the NIH shift to determine the relative contribution of competing pathways of aniline metabolism in the rat. Drug Metab Dispos. 1986 Nov-Dec; 14(6):689-91.
    View in: PubMed
    Score: 0.010
  28. Role of aniline metabolites in aniline-induced hemolytic anemia. J Pharmacol Exp Ther. 1986 Sep; 238(3):1045-54.
    View in: PubMed
    Score: 0.010
  29. Application of cryopreserved human hepatocytes in trichloroethylene risk assessment: relative disposition of chloral hydrate to trichloroacetate and trichloroethanol. Environ Health Perspect. 2006 Aug; 114(8):1237-42.
    View in: PubMed
    Score: 0.009
  30. Strain differences in susceptibility of normal and diabetic rats to acetaminophen hepatotoxicity. Biochem Pharmacol. 1986 Feb 15; 35(4):687-95.
    View in: PubMed
    Score: 0.009
  31. Mechanism of fasting-induced suppression of acetaminophen glucuronidation in the rat. Adv Exp Med Biol. 1986; 197:697-706.
    View in: PubMed
    Score: 0.009
  32. Improved method for determination of cellular thiols, disulfides and protein mixed disulfides using HPLC with electrochemical detection. Adv Exp Med Biol. 1986; 197:407-13.
    View in: PubMed
    Score: 0.009
  33. Hydroxylamines and hemolytic anemia. Adv Exp Med Biol. 1986; 197:573-82.
    View in: PubMed
    Score: 0.009
  34. Primaquine-induced hemolytic anemia: role of splenic macrophages in the fate of 5-hydroxyprimaquine-treated rat erythrocytes. J Pharmacol Exp Ther. 2005 Dec; 315(3):980-6.
    View in: PubMed
    Score: 0.009
  35. Primaquine-induced hemolytic anemia: role of membrane lipid peroxidation and cytoskeletal protein alterations in the hemotoxicity of 5-hydroxyprimaquine. J Pharmacol Exp Ther. 2005 Aug; 314(2):838-45.
    View in: PubMed
    Score: 0.009
  36. Role of UDPGA flux in acetaminophen clearance and hepatotoxicity. Xenobiotica. 1984 Jul; 14(7):553-9.
    View in: PubMed
    Score: 0.008
  37. Induction of peroxisome proliferation in cultured hepatocytes by a series of halogenated acetates. Toxicology. 2004 May 03; 197(3):189-97.
    View in: PubMed
    Score: 0.008
  38. Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine. J Pharmacol Exp Ther. 2004 Apr; 309(1):79-85.
    View in: PubMed
    Score: 0.008
  39. Rapid and sensitive method for the microassay of nitrosobenzene plus phenylhydroxylamine in blood. J Chromatogr. 1983 Oct 14; 277:173-82.
    View in: PubMed
    Score: 0.008
  40. Mechanism of ketone-induced protection from acetaminophen hepatotoxicity in the rat. Drug Metab Dispos. 1983 Sep-Oct; 11(5):451-7.
    View in: PubMed
    Score: 0.008
  41. Primaquine-induced hemolytic anemia: effect of 6-methoxy-8-hydroxylaminoquinoline on rat erythrocyte sulfhydryl status, membrane lipids, cytoskeletal proteins, and morphology. J Pharmacol Exp Ther. 2002 Oct; 303(1):141-8.
    View in: PubMed
    Score: 0.007
  42. Increased resistance of diabetic rats to acetaminophen-induced hepatotoxicity. J Pharmacol Exp Ther. 1982 Mar; 220(3):504-13.
    View in: PubMed
    Score: 0.007
  43. Pharmacokinetic considerations in toxicity testing. Drug Metab Rev. 1982; 13(6):983-1007.
    View in: PubMed
    Score: 0.007
  44. Glutathione thresholds in reactive metabolite toxicity. Arch Toxicol Suppl. 1980; 3:95-110.
    View in: PubMed
    Score: 0.006
  45. Metabolic activation of furosemide to a chemically reactive, hepatotoxic metabolite. J Pharmacol Exp Ther. 1976 Oct; 199(1):41-52.
    View in: PubMed
    Score: 0.005
  46. Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen. Pharmacology. 1974; 12(4-5):251-71.
    View in: PubMed
    Score: 0.004
  47. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology. 1974; 11(3):151-69.
    View in: PubMed
    Score: 0.004
  48. Lack of in vivo evidence of a cytochrome P450 metabolite participating in aminoglycoside nephrotoxicity. Biochem Pharmacol. 1993 Feb 09; 45(3):780-2.
    View in: PubMed
    Score: 0.004
  49. Proceedings: Mechanisms of drug absorption and of drug solution. Rev Can Biol. 1973; 32:Suppl:7-19.
    View in: PubMed
    Score: 0.004
  50. CONVERSION OF STEARIC ACID INTO OLEIC ACID IN ADIPOSE TISSUE. Biochim Biophys Acta. 1964 Aug 05; 84:478-80.
    View in: PubMed
    Score: 0.002
  51. Species differences in hepatic glutathione depletion, covalent binding and hepatic necrosis after acetaminophen. Life Sci. 1974 Jun 01; 14(11):2099-109.
    View in: PubMed
    Score: 0.001
  52. Acetaminophen-induced hepatic necrosis. V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters. Pharmacology. 1974; 12(3):129-43.
    View in: PubMed
    Score: 0.001
  53. Acetaminophen-induced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro. J Pharmacol Exp Ther. 1973 Oct; 187(1):203-10.
    View in: PubMed
    Score: 0.001
  54. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther. 1973 Oct; 187(1):185-94.
    View in: PubMed
    Score: 0.001
  55. Role of detoxifying enzymes in bromobenzene-induced liver necrosis. J Pharmacol Exp Ther. 1973 Oct; 187(1):218-27.
    View in: PubMed
    Score: 0.001
  56. The role of cytochrome P-450 in N-hydroxylation of 2-acetylaminofluorene. Mol Pharmacol. 1973 May; 9(3):398-404.
    View in: PubMed
    Score: 0.001
  57. Drug metabolism as a cause of drug toxicity. Drug Metab Dispos. 1973 Jan-Feb; 1(1):418-23.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.